1. Davis JR, Vanderploeg JM, Santy PA, et al. Space motion sickness during 24 flights of the space shuttle. Aviat Space Environ Med. 1988;59:1185–9.
2. Reschke MF, Harm DL, Parker DE, et al. Neurophysiologic aspects: space motion sickness. In: Nicogossian AE, Huntoon CL, Pool SL, editors. Space physiology and medicine. 3rd ed. Philadelphia: Lea & Febiger; 1994. p. 228–60.
3. Bagain JP. First intramuscular administration in the US space program. J Clin Pharmacol. 1991;31:920.
4. Putcha L, Berens KL, Marshburn TH, et al. Pharmaceutical use by U.S. astronauts on space shuttle missions. Aviat Space Environ Med. 1999;70:705–8.
5. Davis JR, Jennings RT, Beck BG. Comparison of treatment strategies for space motion sickness. Microgravity Q. 1992;2:173–7.